GB Sciences Hosts Its First Medical Cannabis Conference


Ryan Allway

November 3rd, 2014

News, Top News


 GB Sciences (GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize safe and consistent medicinal cannabis, will host its first annual medical cannabis conference on November 14th.

This premiere event, titled “Cannabinoid Science and Medicine: From Plant to Medicine,” will start at 9:30 a.m on November 14, 2014, at the Condado Vanderbilt Hotel in San Juan, Puerto Rico. Co-sponsored by parent GB Sciences and GB Sciences Puerto Rico (GBPR), the event will be cohosted by Dr. Jose A. Franceschini, Chief Medical Officer of GBPR, and Dr. Andrea Small-Howard, Chief Science Officer of GB Sciences.

“Education is the key to providing access for the hundreds of thousands of people around the world who suffer from Alzheimer’s, Parkinson’s, epilepsy, and so many other diseases that would benefit from pharmaceutical-grade cannabis products,” says Dr. Small-Howard. “This educational event will benefit participants by arming them with scientific and medical facts that are not widely available.”

The conference is intended to communicate the latest scientific developments on the utility and efficacy of cannabinoid therapies and to dispel the myths that persist about cannabis, myths that have delayed the acceptance of cannabis as legitimate medicine. The conference will also emphasize economic benefits that are anticipated for Puerto Rico as a result of the clinical trial programs planned by GB Sciences and the extensive operations planned by GBPR.

Speakers include some very knowledgeable people in the medical cannabis industry:

  • Andrea L. Small-Howard, PhD, MBA: GB Sciences’ Chief Science Officer has developed a novel drug discovery engine to find and then validate proprietary cannabinoid therapies through clinical trials planned in Puerto Rico.
  • Craig Ellins: The CEO of GB Sciences has spent years studying cannabis cultivation and supply-chain methods in order to create an unparalleled system for growing, processing, and dispensing medical cannabis that is consistent and safe.
  • José A. Franceschini Carlo, MD, FAPA: As the Chairman of the Department of Psychiatry at the Universidad Central Del Caribe, Dr. Franceschini is one of the best informed and most outspoken supporters of the use of cannabinoid therapies in Puerto Rico.
  • Helen Turner, PhD: Dean of Natural Sciences and Mathematics at Chaminade University and well respected immunologist, Dr. Helen Turner is working with GB Sciences to develop preclinical trials for proprietary cannabinoid therapies and a CME-accredited cannabis educational program for physicians and GB Sciences’ staff.

“Please join us for this eye-opening symposium on the benefits of cannabinoid treatment,” invites Dr. Franceschini. “But reserve your spot soon—we expect a full capacity audience in this invitation only event.”

To register for the conference, call (787) 777-1477 or email [email protected]. To learn more about GB Sciences, Inc., go to www.gbsciences.com.

About GrowBLOX Sciences, Inc.

GB Sciences merges state-of-the-art technologies in plant biology, cultivation technology, and post-production processes in order to optimize our safe and consistent medicinal cannabis. The company is pioneering technology, industry-leading processes, and a big-data-driven clinical research and development algorithm to bring relief to patients in communities across the country.

To learn more about GB Sciences, Inc., go to www.gbsciences.com.

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company’s ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management’s ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company’s filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.



Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading